Insider Selling: Imperva CTO Sells 5,000 Shares of Stock (IMPV)
Imperva (NASDAQ:IMPV) CTO Amichai Shulman sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $30.00, for a total value of $150,000.00. Following the sale, the chief technology officer now directly owns 65,052 shares of the company’s stock, valued at approximately $1,951,560. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Imperva (NASDAQ:IMPV) traded down 3.44% during mid-day trading on Wednesday, hitting $29.19. 358,787 shares of the company’s stock traded hands. Imperva has a one year low of $18.40 and a one year high of $67.12. The stock has a 50-day moving average of $26.3 and a 200-day moving average of $33.40. The company’s market cap is $773.4 million.
Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Thursday, July 31st. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.16. The company had revenue of $38.40 million for the quarter, compared to the consensus estimate of $34.41 million. During the same quarter in the previous year, the company posted ($0.10) earnings per share. The company’s revenue for the quarter was up 22.7% on a year-over-year basis. Analysts expect that Imperva will post $-0.95 EPS for the current fiscal year.
IMPV has been the subject of a number of recent research reports. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Imperva in a research note on Tuesday, August 19th. They now have a $30.00 price target on the stock. Analysts at Piper Jaffray initiated coverage on shares of Imperva in a research note on Tuesday, August 12th. They set a “neutral” rating and a $29.00 price target on the stock. Six analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $37.70.
Imperva, Inc (NASDAQ:IMPV) is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.